Contact

Pharmacology Departmentperforms pharmacokinetic studies, including bioequivalence and bioavailability of medicinal products, in compliance with EMA and FDA guidelines. Since 2003 all work in thePharmacology
Departmenthas been done in accordance with Good Laboratory Practice, which has been recognized by means of GLP certificates issued by the Bureau for Chemical Substances
(Certificate no 4/2018/DPL).
We cooperate with academic and research centres in the area of in vitro comparative study models and new bioanalytical techniques and methods. Our contractors include domestic and foreign pharmaceutical companies. Our staff is involved in consulting of draft EMA guidelines. Bioequivalence studies has been conducted in the Pharmacokinetics Department since 1983. Until 2017 we were known as Pharmacology Department.
Detailed data on the services and cooperating clinical sites (GCP) can be found in the Research offer.

Free on-line tool for visual presentation of incurred sample reanalysis (ISR) data developed by Pharmaceutical Research Institute and Warsaw University of Technology is available at
http://52.31.27.158/isr/
.
This tool assists the paper published in
Bioanalysis, Vol.9, No.12.